Integra LifeSciences/$IART

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Integra LifeSciences

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Ticker

$IART
Primary listing

Industry

Health Care Equipment & Supplies

Employees

4,396

ISIN

US4579852082

IART Metrics

BasicAdvanced
$1B
-
-$0.38
1.27
-

What the Analysts think about IART

Analyst ratings (Buy, Hold, Sell) for Integra LifeSciences stock.

Bulls say / Bears say

Integra LifeSciences reported first-quarter 2025 revenues of $382.7 million, indicating a strong financial performance. (Integra LifeSciences Press Release)
The company launched the Integra Institute for Healthcare Professionals, enhancing its educational outreach and potentially expanding its market presence. (Integra LifeSciences Press Release)
Integra's DuraSeal® Dural Sealant demonstrated cost-saving benefits in healthcare, potentially increasing its adoption and sales. (Integra LifeSciences Press Release)
The FDA issued a warning letter to Integra regarding quality system violations at three facilities, which could impact product approvals and company reputation. (MarketScreener)
A third-party audit revealed additional issues at Integra's Boston plant, delaying the return of key products to the market and potentially affecting revenue. (MedTech Dive)
The company announced the closure of its Indiana facility, resulting in approximately 60 job cuts, which may indicate operational challenges. (MedTech Dive)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.

IART Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IART Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IART

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs